EcoDrugPlus

Prostaglandin E Receptor 3

Ensembl ID : ENSLCAG00010013332
Gene Symbol: PTGER3
4 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSLCAG00010005529
Gene Symbol: LOC108882313
4 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) B

Ensembl ID : ENSLCAG00010000912
Gene Symbol: PTGER4B
4 Cross references
201 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype

Ensembl ID : ENSLCAG00010016503
Gene Symbol: LOC108898709
4 Cross references
164 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSLCAG00010011457
Gene Symbol: PTGFR
1 Cross references
192 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSLCAG00010017489
Gene Symbol: PTGFR
1 Cross references
192 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSLCAG00010011648
Gene Symbol: PTGFR
1 Cross references
192 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSLCAG00010012960
Gene Symbol: PTGFR
1 Cross references
192 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSLCAG00010019043
Gene Symbol: PTGIR
4 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSLCAG00010017161
Gene Symbol: PTGS1
4 Cross references
212 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSLCAG00010002329
Gene Symbol: PTGS1
1 Cross references
182 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSLCAG00010008447
Gene Symbol: PTGS2B
1 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).